SONAZINE (CHLORPROMAZINE HYDROCHLORIDE) — FDA Approval ANDA080983 (SAPTALIS PHARMS)
SONAZINE (CHLORPROMAZINE HYDROCHLORIDE) — FDA Approval ANDA080983 (SAPTALIS PHARMS) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: SONAZINE; Active ingredients: CHLORPROMAZINE HYDROCHLORIDE; Application number: ANDA080983.
| Brand name | SONAZINE |
|---|---|
| Active ingredients | CHLORPROMAZINE HYDROCHLORIDE |
| Application number | ANDA080983 |
| Sponsor | SAPTALIS PHARMS |
| Dosage form | CONCENTRATE |
| Route | ORAL |
| Marketing status | Prescription |
| Products in application | 2 |
| First approval date | 19760301 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →